2007, Diabetes and IT - Primary Care Digest

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2007

Diabetes

Biased research, aggressive sales, harmful drugs

The Health Policy Exchange

MAY 20, 2013

In this month's Georgetown University Health Policy seminar, we discussed two examples, anemia drugs and the diabetes drug rosiglitazone (Avandia) , which were prominently featured in recent articles by Peter Whoriskey in The Washington Post. The size of average doses would more than triple.

Manufacturing

Manufacturing Family Medicine DO Patients

Bisphosphonates for Osteoporosis: Podcast with James Deardorff and Sei Lee

GeriPal

FEBRUARY 17, 2022

When we have a medication with up front harms and downstream benefits, it’s critical that we consider the time to benefit, or how long it will take an individual to benefit from a test or treatment. Think of the 10 years it takes to benefit from colon or breast cancer screening, which is designed to detect slow growing cancers. See screenshot below.

Clinic

Clinic IT Patients Medical

Biased research, aggressive sales, harmful drugs

Bisphosphonates for Osteoporosis: Podcast with James Deardorff and Sei Lee

Stay Connected